Skip to main content Deutsch

Ludwig Boltzmann Institute Applied Diagnostics (LBI AD)

Department of Health Economics (DHE)


Date: 2016–2023
Funder: LBG
Information: Judit Simon (co-PI), Ines Stelzer

The recently established international, transdisciplinary Ludwig Boltzmann Institute Applied Diagnostics (LBI AD) in Vienna, Austria, focuses on the development and application of non-invasive dual diagnostic methods (combining molecular epigenetic and genetic signatures and molecular imaging biomarkers) to allow for improved tumour diagnosis and characterisation, and its translation into personalised patient care. The strong link between clinical and basic science related projects researched also from broader social sciences aspects within the institute provides an excellent basis for transdisciplinary research and training.

Professor Judit Simon is one of the key researchers of the LBI AD leading a specific program line on relevant broader socioeconomic research questions. The program line focuses on methodological and applied health economics research questions in the areas of personalised oncology diagnosis and treatment including individual patient-level data analyses, decision analytic modelling, health technology assessment, and value of information analysis in order to support the development of cost-effective test-treatment strategies and to assess their budget impact. Relevant ethical, social and legal considerations are also researched. The program line is further supported by Professor Uwe Siebert and Professor Alena Buyx.